Society of Cannabis Clinicians

Kickoff Event for SCC Latin American Chapter & Spanish Courses
2023-09-13 09:00 - 10:00 (America/Los_Angeles)
Join us for a special kickoff event to celebrate the re-launch of the Latin American (LATAM) Chapter as well as the new courses available in Spanish!
Este paquete de 5 cursos cubre la ciencia esencial sobre el sistema endocannabinoide, la botánica, la farmacología, el análisis de laboratorio y la dosificación y administración del cannabis medicinal.

Descripción general del Sistema Endocannabinoide
Botánica, Ecología y Fitoquímica del Cannabis
Farmacología del cannabis: farmacocinética, farmacodinámica e interacciones farmacológicas
Análisis de laboratorio: Aseguramiento de la calidad y productos de cannabis
Dosis y administración de la medicina del cannabis

Note: the event will be in Spanish.
Register

Medical Cannabis Conference
2023-09-02 08:30 - 20:30 (America/Los_Angeles) | Neuroscience Research Building (NRB), UCLA, Neuroscience Research Building (NRB), 635 Charles E Young Drive South, Los Angeles, 90095
This clinical cannabis conference is the first national conference hosted by the Society of Cannabis Clinicians and features authors of the SCC Clinical Training Curriculum. Join us at this exclusive event to hear directly from world-renowned cannabis experts who have combined decades of experience utilizing medical cannabis in their diverse patient populations.
Location: UCLA
Neuroscience Research Building (NRB)
635 Charles E Young Drive South
Los Angeles, CA 90095
ACCME Joint Provider Accreditation Statement:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Saint John’s Health Center and Society of Cannabis Clinicians. Saint John’s Health Center is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
Saint John’s Health Center designates this Live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Agenda

8:30 am

Welcome: Sherry Yafai, MD
Intro by MC, Dilara Uksup, PhD, PhD

9:00 am
Genester Wilson-King, MD: Cannabis and Endometriosis: It Should be a Treatment Option Now

10:00 am
Patricia Frye, MD: Exploring the Potential Benefits of Cannabis in Autism Spectrum Disorders

11:00 am
Bonni Goldstein, MD: Clinical Effects of Two Important Cannabinoids: CBDV and CBG

12:00 pm
Tim Fong, MD: 2023 Updates to Management of Cannabis Use Disorder

---- 12:30 PM BREAK for LUNCH ----

1:15 pm
Sherry Yafai, MD: Dementia and Palliative Care: Where and how can Cannabis be used?

2:15 pm
Jacqueline Campion: The Department of Cannabis Control’s Academic Research Grant Program

2:45 pm
Reji Varghese, MBC: Medical Board of California Cannabis Recommendations

3:15 pm
Dr. Imani Brown, City of Los Angeles Department of Cannabis Regulation: The Importance of Social Equity in the Licensed Cannabis Market

3:45 pm
Roundtable discussion:
Department of Cannabis Control, Medical Board of California, City of Los Angeles Department of Cannabis Regulations

—- 15 Minute Break —-

4:30 pm
SCC Closing Remarks - Stephen Robinson, MD, MPH

5:00 pm close
Networking & Sponsorship Booth Exhibition

6:00 - 8:00 pm
Happy Hour at The Hideout (The W Hotel) hosted by MedinaCBD: 930 Hilgard Ave Los Angeles CA 90024

Close

Meet the speakers

Bonni Goldstein, MD

Dilara K. Üsküp, Ph.D

Genester Wilson-King, MD

Patricia Frye, MD

Reji T. Varghese, MBC

Stephen Robinson, MD, MPH

Timothy W. Fong, MD

Imani Brown, PhD

Jacqueline Campion

Bonni Goldstein, MD

Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness & Education, a California-based medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions. She completed her internship and residency at Children’s Hospital Los Angeles, where she also served as chief resident. After years of working in the specialty of Pediatric Emergency medicine, she developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend. Over the last 15 years she has evaluated thousands of patients for use of medical cannabis and is recognized as an expert in the clinical application of cannabis therapeutics. She has a special interest in treating children with intractable epilepsy, autism, cancer and other conditions. Her latest book, “Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain” was published in September 2020 by Little, Brown Spark. Dr. Goldstein is currently researching the use of Cannabis-Responsive biomarkers to document objective cannabis treatment efficacy, guide clinical decision-making and improve outcomes.

Close

Dilara K. Üsküp, Ph.D

Dilara K. Üsküp, Ph.D. is an Assistant Professor in Internal Medicine at Charles R. Drew University of Medicine and Sciences and an Investigator in the Department of Family Medicine at the University of California, Los Angeles. Dr. Üsküp is a joint doctoral graduate of the University of Chicago’s Department of Political Science and the Divinity School. She was the first in the University’s history to be awarded both a Ph.D. in political science and a Ph.D. in theology from the Divinity School. She completed her NIH/NIMH training at the UCLA Center for HIV Identification, Prevention, and Treatment Services. Her research investigates the ways religious and political institutions, attitudes, and ideology interacts and shape health behavior to inform public policy. She is also an ordained minister. Her burgeoning research portfolio includes the areas of politics and theology, HIV prevention, cannabis and social equity, and health policy. She collaborates and consultants with faith-based and faith-placed cannabis organizations that are engaged in social justice work around incarceration/citizen reentry, employment/job creation, economic development, health equity, and cannabis social equity. She is co-principal investigator of CaliCANN, a demographic analysis of the state of California cannabis market.

Close

Genester Wilson-King, MD

Genester Wilson-King, MD FACOG is a Board-Certified Obstetrician and Gynecologist with over 20 years of clinical experience providing compassionate and research-driven care to patients. In 2010, she founded Victory Rejuvenation Center (VRC), a private holistic and integrative wellness medicine practice that provides life-transforming management modalities and customized medicines to patients.
She is Vice President of the Society of Cannabis Clinicians, a non-profit that works to empower and educate healthcare providers on the use of cannabis medicine. She is a member of the Special Advisory Board of the Association for Cannabis Health Equity and Medicine, ACHEM, an organization that is a mutual benefit, professional medical association for BIPOC healthcare professionals and students active or interested in cannabinoid medicine and health equity. And finally, she is on the Board of Directors for Doctors for Drug Policy Reform, a national physicians’ association dedicated to the legalization and regulation of cannabis and psychedelics for adults.
A co-author of published articles on the Assessment of the Impact of Cannabis on Female and Male Sexual Function. Dr. Wilson-King is an expert on cannabis use in female health and Hormone Therapy for females and males.

Close

Patricia Frye, MD

Patricia Frye M.D. began her journey with medicinal cannabis as the first evaluating physician for a cannabis telemedicine platform, HelloMD. This was her first introduction to the use of cannabis as medicine and it proved to be an invaluable and career-changing experience. Intrigued by the testimony of thousands of patients and what she learned from the scientific literature, Dr. Frye went on to become professionally certified in Cannabis Science and Medicine by the University of Vermont School of Medicine.
Now in private practice, Dr. Frye focuses on the role of cannabis in the management of chronic pain, inflammation, autoimmunity, neurodegenerative disorders, autism, seizure disorders, and psychiatric conditions. She works closely with patients and their referring clinicians to develop sound treatment plans that are based on both observational and scientific evidence.
Dr. Frye earned her medical degree at the University of Maryland School of Medicine, where she also trained in pediatrics, and is certified by the American Board of Pediatrics. After completing her pediatric residency, she trained in Anesthesiology at Baylor College of Medicine where she gained experience working with adult patients in medical pain management and pain management procedures.
During her many years at Kaiser Permanente in Southern California her practice focused on children and teens with autistic spectrum disorder, learning and developmental disabilities, school problems, and behavior issues. She has served as a volunteer for several organizations which include the St. Mary’s AIDS Care Team, Phoenix House, an in-patient drug rehabilitation program for adolescents, Head Start Committee on Health, and Piedmont CASA where she served as an advocate for children in the family court system due to abuse or neglect.
Dr. Frye lectures internationally, educating medical providers, patient groups, policy makers, businesses, and government agencies on the endocannabinoid system and medical benefits of the cannabis plant. She serves on the Cannabis Trade Federation Task Force on Diversity, Equity, and Inclusion and the board of the Society of Cannabis Clinicians. In 2018 she authored the book “The Medical Marijuana Guide: Cannabis and Your Health”.

Close

Reji T. Varghese, MBC

Mr. Varghese is serving as Deputy Executive Director of The Medical Board of California (MBC) for the past two years and seven months and as of February 17, 2023 the Board appointed him to the position of Interim Executive Director. Prior to joining MBC, he served, for 10 (ten) years, The Oklahoma Board of Medical Licensure and Supervision (OMB) in the capacity of Deputy Executive Director. He started working at OMB from November 1989 and served in different capacity, various positions, and departments. In total he has over 33 years of experience in medical regulatory field.
He obtained bachelor’s degree in economics/commerce from MG University, India.
Varghese is an active member of California Department of Consumer Affairs’ DEI steering committee. He also served on the Board of Directors of; The Telehealth Alliance of Oklahoma, member of The Allied Tele-health sub-committee for the Board, South Indian Cultural Association of Oklahoma.
Also, served as Board member of several organizations to include Putnam City Public Schools Oklahoma, Oklahoma Public Purchasing Association, St. George Syriac Orthodox Christian Church, Council representative to American Archdiocese of Syriac Orthodox Churches, Director of National Sunday School Association.

Close

Stephen Robinson, MD, MPH

Dr. Stephen S. Robinson grew up in Newark, NJ and graduated from Reed College in Portland, Oregon and the University of Washington Medical School in Seattle. Dr. Robinson completed his MPH at Johns Hopkins School of Hygiene and Public Health.
His interest in both public health and global health became a lifelong commitment after his first visit to Cuba in the early ’70s. He completed his residency in internal medicine at Harlem Hospital Center and later served as a medical team leader to Ghana and Liberia with Operation Crossroads Africa.
In New York City, Dr. Robinson worked within the Sophie Davis School at the City College of New York for 15 years, to establish the CUNY Medical School. Esteemed colleagues included the late Dr. George I. Lythcott. During his tenure with the City University, Robinson also served as the interim director of the Physician Assistant Program at Harlem Hospital Center.
After working as Medical Director with Georgia’s Primary Care Assn., he left the US for five years and worked in Tanzania, setting up an exchange program between the Institute for Medical Research in Tanzania and the Public Health Sciences Institute at Morehouse College. While there, he also worked with Columbia University’s Mailman School of Public Health evaluating health facilities for their readiness to provide HIV/AIDS care and treatment.
Since his move to Oakland, California in 2010, Dr. Robinson has been evaluating patients for their use of medical cannabis. He participated on panels at numerous cannabis-related conferences and delivered presentations on cannabis’ medicinal benefits and dosing strategies to both professional and lay audiences. Dr. Robinson contributed to the revision of the Medical Board of California’s “Guidelines for the Recommendation of Cannabis for Medical Purposes.” He has been a board member of the Society for Cannabis Clinicians, and currently serves as president of the organization.

Close

Timothy W. Fong, MD

Dr. Fong is a Professor of Psychiatry at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA. He is board certified in adult and addiction psychiatry.
He is the co-director of the UCLA Gambling Studies Program. The purpose of this program is to examine the clinical characteristics of gambling disorder in order to develop effective, evidence-based prevention and treatment strategies.
Dr. Fong is also a member of the Steering Committee of the UCLA Center for Cannabis and Cannabinoids whose mission is to address the most pressing questions related to the impact of cannabis legalization through rigorous scientific study and discourse across disciplines.
He is the Director of the UCLA Addiction Psychiatry Consultation Service and an an attending physician in the UCLA Addiction Psychiatry Clinic.

Close

Imani Brown, PhD

Dr. Imani Brown is an urban policy and economic development professional with more than 25 years’ experience in the areas of public policy, sustainable urban land use, government relations and small business development. She is currently the Social Equity Program Director for the City of Los Angeles Department of Cannabis Regulation. Her programs’ focus is equity business development, education, technical assistance, grants, pro bono & low bono legal services, workforce development and the advocacy and creation of equity centered policy reforms.
For many years she served as the Managing Partner for a smart growth, sustainable land use development company. Dr. Brown was formerly the Executive Director of External Partnerships of Government & Civic Engagement at USC, where she was the principle negotiator for the Community Benefits Agreement package for the University Village, a multibillion dollar economic development project. As Associate Vice President of University & Government Relations at California State University Dominguez Hills, she served as the chief liaison for the University in the development of the privately owned Stub Hub Sports Arena (Currently Dignity Health Sports Park). She served as Chief Deputy of Small Business, Transportation and Housing for the late Congresswoman Juanita Millender-McDonald of the 37th Congressional District, where she created small business incubators and workforce development opportunities for communities impacted by the Alameda Corridor Project. She has negotiated multi million dollar professional services contracts in the public and private sectors and co
founded The Vendor Relations Department for the Metropolitan Transportation Authority (MTA).
She has served on numerous non-profit boards, and chaired the board of directors for T.H.E Clinics of Los Angeles, The Ashley Morgan Spiller Cancer Foundation, and the Gordon/Brown Fellowship. Dr. Brown was most recently appointed by the State of California to serve on the Board of the Cannabis Advisory Committee.
She has produced art events for international artists, and raised funding and awareness for battered women and children. She promotes financial literacy and mentors college bound urban youth in Los Angeles. Dr. Brown is passionate about building an equity centered licensed Cannabis industry at the local, state, federal and international levels.

Close

Jacqueline Campion

Jacqueline Campion is the Deputy Director of Policy and Research at the California Department of Cannabis Control (DCC), the state agency that licenses and regulates cannabis businesses. The Policy and Research Division of DCC develops regulations and policy recommendations that advance the sustainability, safety, and equity of the legal cannabis market and benefit all Californians. To support informed policy decisions, this division conducts research, administers research grants, and facilitates collaboration with stakeholders, other state agencies, and global government entities.

Close

Register

UIC 2023: Australian Medical Cannabis Symposium
2023-08-11 08:00 - 2023-08-13 17:00 (America/Los_Angeles) | Brisbane Convention & Exhibition Centre, South Bank Parklands, Brisbane, QLD 4101, Australia
On behalf of United in Compassion (UIC), The Australian Medicinal Cannabis Association (AMCA) and the Society of Cannabis Clinicians Australian Chapter (SCCAC), I am excited to invite you to attend the 2023 Australian Medicinal Cannabis Symposium to be held at the Brisbane Convention and Exhibition Centre from the 11-13 August 2023.

SCC and Csequence Journal Club Presents: Mark Viner, MD on State Cannabis Legalization and Psychosis-Related Health Care Utilization
2023-06-07 09:00 - 10:00 (America/Los_Angeles)
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s installment will hear Dr. Mark Viner discuss the recently published article, State Cannabis Legalization and Psychosis-Related Health Care Utilization.
Register

Quarterly Meeting: Featuring Douglas Bruce, PhD, MSW on Cannabis & HIV
2023-05-26 09:00 - 10:00 (America/Los_Angeles)
Join us for a special Quarterly Meeting featuring Dr. Douglas Bruce on the topic of: The spectrum of cannabis use among young persons living with HIV/AIDS.
Douglas Bruce, PhD, MSW is a public health researcher and earned his PhD in public health from the University of Illinois at Chicago. His mixed methods research focuses on the health behavior of persons living with chronic conditions, including the secondary prevention needs of young persons living with HIV/AIDS, and the role of cannabis in the lives of persons living with chronic disease. He has served as principal investigator on grants from the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Child Health and Human Development. As a program evaluation and development consultant, Dr. Bruce has worked with a number of local organizations, such as the AIDS Foundation of Chicago and Chicago Department of Public Health, as well as national and international organizations, including the Centers for Disease Control and Prevention and the US Agency for International Development.
Register

CannMed Medical Practicum
2023-05-15 08:00 - 10:00 (America/Los_Angeles) | Marco Island, FL, Marco Island, FL, United States
This workshop is for clinicians exploring the therapeutic potential of medicinal plants, or laypersons looking to understand these medicines at a clinical level. It begins with an exploration of the human endocannabinoid system, and takes a deep dive into how these plants work to alleviate a host of conditions, including dosing, safety, efficacy, side effects, and more. Full day with CME and CEU credits available. We are proud to announce that all of the practicum speakers are long-time members of the SCC.
Register

Book Launch with Peter Grinspoon, MD -- Seeing through the Smoke: A Cannabis Specialist Untangles the Truth about Marijuana
2023-05-10 09:00 - 10:00 (America/Los_Angeles)
This edition of the SCC / Csequence Journal Club will feature Peter Grinspoon, MD as he discusses his new book (available on April 20, 2023).
You can pre-order the book here.
Description:
Depending on which doctor you speak with, or which websites you read, cannabis could be an appealing, low-risk medicine – even an aid to wellness – or an insidiously addictive drug rotting the brains of our youth. This dissonance confuses young people, distressed patients, and paralyzes politicians, all while inviting dubious sources of information and resulting in uninformed choices, enhanced polarization, and a fragmented national policy.
Seeing Through the Smoke is an unflinching examination at the grossly misunderstood drug that uses data-driven medical science and a critical historical perspective to reveal the truth behind cannabis. In this balanced and measured investigation, Cannabis specialist and Instructor in Medicine at Harvard Medical School Dr. Peter Grinspoon untangles the reality behind cannabis, revealing how we ended up with radically divergent understandings of the drug and pointing a way toward a middle ground that we can all share.
Moving through an illuminating tour of the social history and the medical science behind cannabis, Grinspoon unpacks the layers of disinformation left by a sordid history of government propaganda, racial suppression, and indifference from the medical community to answer questions like:

Is cannabis addictive?
What are its best-established medical uses?
Can cannabis help cure cancer?
How does cannabis affect memory?
How dangerous is cannabis for teens?
Is cannabis a safer treatment for ADHD and PTSD?
What exactly is CBD and how is it different from marijuana?
What are the most concerning side effects?

By focusing on the most critical purported harms—driving, pregnancy, addictiveness, memory—and by focusing on the most commonly cited medical benefits—relieving chronic pain, sleep, anxiety, PTSD, autism, and cancer—Seeing Through the Smoke will help patients, parents, doctors, health experts, regulators, and politicians move beyond biased perceptions and arrive at a shared reality towards cannabis.
Register

Special Presentation: Fred Gardner & Dr. Jeffrey Hergenrather on the History of SCC
2023-04-28 09:00 - 10:00 (America/Los_Angeles)
Join us for this Special Presentation with Fred Gardner and Dr. Jeffrey Hergenrather as they recount pivotal moments in California’s medical cannabis movement — Proposition 215, Dr. Tod Mikuriya, and the formation of the California Cannabis Research Medical Group (CCRMG) / Society of Cannabis Clinicians.
Register

Roundtable Discussion on the New Certification in Basic Cannabinoid Medicine
2023-04-20 09:00 - 10:00 (America/Los_Angeles)
Register

SCC and Csequence Journal Club Presents: Adam Abodeely, MD, MBA on Cannabinoids & Gastrointestinal Ailments
2023-04-05 09:00 - 10:00 (America/Los_Angeles)
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s installment will hear Dr. Adam Abodeely discuss his research on cannabinoids & gastrointestinal ailments.
Article:
The minor cannabinoids and their potential implications for conditions of the gastrointestinal system
Register

International Committee: Cannabis in Thailand by Dr. Shiksha Gallow
2023-03-30 08:30 - 09:30 (America/Los_Angeles)
Dr. Shiksha Gallow presents to the SCC International Committee an update on Medical Cannabis in Thailand. Join us on Thursday, March 30th to hear all of the need to know information on what is happening politically in the Thailand medical cannabis movement, and where clinicians’ rights to practice cannabis medicine stand.
This is a SCC Members Only event. Must log in to your SCC account to register.
Register

SCC and Csequence Journal Club Presents: CBD & the Brain with Jong Rho, MD
2023-03-15 09:00 - 17:00 (America/Los_Angeles)
This Journal Club series hosts monthly educational events where authors discuss their newly published scientific findings. Presentations will focus on a variety of articles and perspectives related to cannabis medicine, including but not limited to clinically-relevant articles and research methodology-focused papers.
This month’s installment will hear Dr. Jong Rho discuss his research on how “Cannabidiol Impairs Brain Mitochondrial Metabolism and Neuronal Integrity.”
Jong M. Rho, MD
Dr. Rho is a Professor of Neurosciences, Pediatrics and Pharmacology at the University of California, San Diego, and Division Chief of Pediatric Neurology at the Rady Children’s Hospital San Diego. He received an undergraduate degree in molecular biophysics and biochemistry at Yale University, and an M.D. from the University of Cincinnati. Dr. Rho has held prior faculty appointments at the University of Washington (Seattle) and the Seattle Children’s Hospital, the University of California at Irvine, the Barrow Neurological Institute (Phoenix), University of Arizona and Arizona State University, and most recently, the University of Calgary and the Alberta Children’s Hospital. Dr. Rho’s main research interests are the mechanisms underlying the anti-seizure and neuroprotective effects of metabolism-based treatments such as the ketogenic diet. His research activities have been sponsored by research grants from the U.S. National Institutes of Health, Canadian Institutes of Health Research, Brain Canada, and a variety of intramural and extramural public and private sector sources.
Register

Quarterly Meeting: Featuring Igor Grant, MD, FRCP(C)
2023-02-17 09:00 - 10:00 (America/Los_Angeles)
Description
Igor Grant, M.D., F.R.C.P. (C)
Distinguished Professor, UC San Diego, Department of Psychiatry
Director, Center for Medicinal Cannabis Research
Dr. Igor Grant is Distinguished Professor and director of the HIV Neurobehavioral Research Program and the Center for Medicinal Cannabis Research at the University of California San Diego (UCSD). Dr. Grant served as Chair of the UCSD Department of Psychiatry from 2014-2019. He is a neuropsychiatrist who graduated from the University of British Columbia School of Medicine (1966), and received specialty training in psychiatry at the University of Pennsylvania (1967-1971), and additional training in neurology at the Institute of Neurology (Queen Square) (1980-1981), London, U.K. Dr. Grant’s academic interests focus on the effects of various diseases on brain and behavior, with an emphasis on translational studies in HIV, and drugs of abuse. He has contributed to approximately 800 scholarly publications and is principal investigator of several NIH studies.
Since 2000, Dr. Grant has been Director of the State of California funded Center for Medicinal Cannabis Research (CMCR). The Center was funded following passage of California Prop 215, the “Compassionate Use Act” which envisioned providing patients under doctor supervision with access to medicinal cannabis in patients whose condition warranted it. California established the CMCR to develop a knowledge base concerning cannabis.
Headquartered at the University of California San Diego (UCSD), the Center has completed several studies on medical cannabis in relation to neuropathic pain and muscle spasticity in Multiple Sclerosis, as well as cannabis and driving impairment. Results of the studies have been published in the scientific literature and are available at: http://www.cmcr.ucsd.edu/, many found evidence of at least short term benefit of medicinal cannabis.
Currently the CMCR is conducting a number of studies on both therapeutic potentials (e.g., with pain, autism, anxiety, metabolic syndrome, and diabetes) and potential risks (e.g., automobile driving) of medicinal cannabis. Studies are beginning to explore modes of administration and specific cannabinoids (e.g., THC, CBD).
CMCR has been the source of authoritative information that is developing on medicinal cannabis and has consulted with the Legislature of the State of California, the Office of the Lieutenant Governor of California (Blue Ribbon Commission’s Regulatory & Tax Structure Working Group), and contributed to the recent National Academies report, “The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research” (2017).
Register

Natural Healing Hawaii - A naturopathic lifestyle EXPO
2023-02-04 09:00 - 2023-02-05 18:00 (America/Los_Angeles) | Blaisdell Exhibition Hall
The natural medicine focused expo is a great opportunity for healthcare professionals to collaborate together and discuss current issues, receive educational information, and dialogue on key issues like the Dual Use of Cannabis Task Force panel discussion which includes Ryan’s Law.
While there you can also buy some of the best medical cannabis books and informative material. Please bring strong shopping bags! Hope to see you there!
Register

Canna Talk: Pharmacy Edition -- Featuring Farzana Kennedy, RPh, BSPharm, FACA
2023-01-11 09:00 - 10:00 (America/Los_Angeles)
Join us for “Canna Talk: Pharmacy Edition” on January 11th as we hear from our special guest Farzana Kennedy, RPh, BSPharm, FACA. Dr. Kennedy will discuss her background, how she became involved in cannabis medicine, and answer pertinent questions related to her course module on Cannabis and Policy: Impacts on the Healthcare Environment as part of the new curriculum “Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry.”
This educational webinar series is free for all to attend.
Established cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above.
Speakers:
Farzana Kennedy
Alan Ao
Bobby Vincent
Speaker bio:
Farzana Kennedy, RPh, BSPharm, FACA, is the owner, president, and director of clinical operations of NewLeaf, a West Virginia medical cannabis operator. She is a founding member and past president and pharmacist in charge of Dalitso LLC in Virginia where she managed all cultivation, processing, and dispensary functions.
As a founding board member and the inaugural president of the Virginia Medical Cannabis Coalition (VMCC) Farzana worked to establish and expand Virginia’s medical cannabis program by being involved in the regulatory and legislative process. She is also the chair of the Virginia Pharmacist Association (VPhA) Academy of Medical Cannabis and provides Virginia pharmacists with cannabis industry training and education.
Farzana has over twenty-five years of compounding and clinical pharmacy experience, most notably as the former owner and president of Alexandria Compounding Pharmacy. She is an appointee to the Northern Virginia Regional Human Rights Committee (NVRHRC) and is currently working with Virginia Department of Behavioral Health and Developmental Services as a COVID-19 clinical pharmacist consultant for the mental health and substance use disorder population.
Farzana received her pharmacy degree from Howard University School of Pharmacy. She is a 2023 MS candidate at the University of Maryland Baltimore Graduate School Medical Cannabis Science and Therapeutics program and is a member of several professional pharmacy and cannabis organizations.

Canna Talk: Pharmacy Edition -- Featuring Codi Peterson, PharmD, MS
2022-12-07 09:00 - 22:00 (America/Los_Angeles)
Join us for “Canna Talk: Pharmacy Edition” on December 7th as we hear from our special guest Codi Peterson, PharmD, MS. Dr. Peterson will discuss his background, how he became involved in cannabis medicine, and give the insider view on the two courses he developed as part of the new curriculum “Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry.” This educational webinar series is free for all to attend.
Cannabis: A Rich History Clouded in Stigma
The journey of cannabis through the millennia is woven between stories of agriculture, medicine, spirituality, and recreation. The pathway to modern-day reformation requires an understanding of how political agendas shaped cannabis into the polarizing topic it is today. This course addresses cannabis prohibition and how the subsequent War on Drugs has disproportionately affected BIPOC communities. Course participants will learn how the stigmatization of cannabis and its consumption continues to exist today as a multifaceted issue.
The Future of Cannabis Medicine
The future of cannabis and cannabinoid-based medicine is riddled with competing interests and powerhouse industries. Prohibition has led to difficulties studying the cannabis plant on both a molecular level as well as large scale clinical trials. The endocannabinoidome is an expanded scope of what science currently knows and the questions that still need to be resolved as we move forward. The future implications of this knowledge are boundless and have the potential to significantly influence our approach to medical practices. Course participants will gain an understanding of the relationship between varying cannabinoid activity and the endocannabinoid system (ECS), become familiar with the expanded scope of the endocannabinoidome (eCBome), and much more.
Established cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above.
Speakers
Bobby Vincent
Alan Ao
Codi Peterson
Speaker bio:
Dr. Codi Peterson is a pediatric pharmacist and cannabis science expert. Leveraging a decade of clinical pharmacy experience, Codi strives to bridge the gap between healthcare and cannabis through education and advocacy. He is PharmD graduate from Duquesne University and later graduated with an MS in Medical Cannabis Science & Therapeutics. Codi is the Chief Science Officer of The Cannigma, a science forward media company who wants to help the world get cannabis. Dr. Peterson is also an educator for OCEMT where he teaches pharmacology to paramedics in southern California. Codi is co-founder of the Pharmacists Cannabis Coalition of California (PCCC), a public-benefit nonprofit dedicated to educating and elevating California pharmacists in the cannabis space. Additionally Codi is an advisor to numerous companies in the cannabis industry, including Hembel and the Cannabis Spa Association. He believes that cannabis is medicine and patients deserve access to medicine, which includes the right to speak with a healthcare professional.

Canna Talk: Pharmacy Edition -- Featuring Michael Ruggiero, PharmD, AAHIVP
2022-11-16 09:00 - 10:00 (America/Los_Angeles)
Join us for “Canna Talk: Pharmacy Edition” on November 16th as we explore The Cannabis Pharmacist: A Bottom-up Clinical Approach with Michael Ruggiero, PharmD, AAHIVP. Dr. Ruggerio will discuss his background, how he became involved in cannabis medicine, and provide a glimpse into the material covered in his course. This course addresses the primary differences between the medical cannabis industry and traditional pharmaceuticals, teaches participants how to confidently develop tailor-made dosing protocols for patients, and how to comprehend the nuances of various dosage forms and ROAs for cannabinoid-based products, along with much more. If you are interested in taking the course beforehand so that you can ask your questions live, you can purchase the course here.
This educational webinar series is free for all to attend.
Established cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above.
Speakers:
Alan Ao
Bobby Vincent
Michael Ruggiero
Speaker Bio:
Dr. Michael Ruggiero is the Regional Pharmacy Manager for Beyond / Hello in Pennsylvania. Prior to entering the Cannabis Industry he worked as a community pharmacist with certifications in medication therapy management, HIV, and cannabis. Since beginning to work in the industry he has given educational presentations on cannabis to healthcare and non-healthcare professionals alike, spoke on a podcast for Cannigma, provided Veteran driven education, created knowledge assessments for his team, developed oral product formulation dosing charts for the products at his dispensary, and currently is Vice President of International Society of Cannabis Pharmacists. In addition he teaches HIV pharmacotherapeutics to Physician Assistant students at Thomas Jefferson University.

Canna Talk: Pharmacy Edition -- Featuring Curriculum Co-Directors
2022-10-12 21:30 - 22:30 (America/Los_Angeles)
Don’t miss the kickoff event “Canna Talk: Pharmacy Edition” on October 12th as we explore the course material that is covered in the new curriculum: Cannabis Pharmacy: The Modernization of a Novel Healthcare Industry.
This educational webinar series is free for all to attend. The curriculum co-directors Alan Ao, PharmD and Bobby Vincent, III, PharmD, RPh will share a brief overview of what course participants can expect to learn after completing this curriculum and will also delve deeper into the specific topics that Dr. Alan Ao covers in his module The Cannabis Pharmacist: A Bottom-up Clinical Approach. Learn more in their bios below.
Established cannabis pharmacists and clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link above.
Speakers:
Alan Ao, PharmD, Bobby Vincent
Alan Ao, PharmD
Dr. Alan Ao is a registered pharmacist and lifelong NJ native. With over 20 years of retail experience, the majority of his professional career has been spent working alongside patients in independent retail settings specializing in patient care counseling, prescription drug compounding, and alternative medicine. Dr. Ao served as Vice President/Clinical Pharmacist in one of New Jersey’s first vertically integrated alternative treatment centers for 2.5 years before launching his own consulting firm. He’s the Founder and President of Plants and Prescriptions – a consulting firm developing an industry where cannabis and modern-day healthcare collide through education and advocacy. He currently serves as an advisory board member for the Association of Cannabis Health Equity and Medicine and pharmacy course director for the Society of Cannabis Clinicians. Dr. Ao is also involved as a course instructor for dispensary operations for both NJ Cannabis Certified and the Minority Cannabis Academy.
Bobby Vincent, III, PharmD, RPh
Bobby Vincent, III, PharmD, RPh is a Clinical Cannabinoid Pharmacotherapist born and raised in Richmond, Virginia. Dr. Vincent is driven by a passion to bridge the medical cannabis industry with communities in need. Dr. Vincent currently serves the northern Virginia and Washington, D.C. metropolitan area as a pharmacist and medical consult– providing care for hundreds of cannabis patients. Dr. Vincent is the founder of Cannabis Health Alliances, LLC., building partnerships to advance therapy, policy and patient accessibility. He also serves as the Communications Chair for the Virginia Pharmacists Association Academy of Medical Cannabis and a member of the organization’s Task Force for Racial Diversity, Equity, and Inclusion.
Dr. Vincent is a graduate of Hampton University where he obtained a Doctor of Pharmacy degree. He recently earned his Masters of Cannabis Science and Therapeutics Degree at the University of Maryland, Baltimore – the first degree of its kind available in the United States. He has experienced a host of unique learning opportunities, including time abroad in Thailand, United Arab Emirates, and the Philippines as a medical volunteer. Dr. Vincent also spent time with the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) Office of Science Policy and Communications as a pharmacy intern.
To join as a listener, enter code 856348569
Register to Attend

Monthly Journal Club – Dr. Thomas Marcotte, The Complex Relationship Between Cannabis and Driving
2022-10-07 09:00 - 10:00 (America/Los_Angeles)
Speaker:
Thomas Marcotte, PhD
Article:
Driving Performance and Cannabis Users’ Perception of Safety: A Randomized Clinical Trial
Meet Dr. Thomas Marcotte:
Dr. Thomas Marcotte is Professor of Psychiatry at the University of California, San Diego, and Co-Director of the Center for Medicinal Cannabis Research, which has conducted clinical trials of cannabis for over 20 years and has an active, ongoing portfolio exploring the effects of cannabinoids (plant-based, synthetic) in various medical/psychiatric conditions. He is the principal investigator on studies addressing the effects that cannabis has on driving performance, including in combination with alcohol, as well as methods for detecting cannabis-related driving impairment. He is currently a principal investigator on a study examining cannabis for the treatment of sports-related injuries in elite athletes, and previously was the principal investigator on an NIH-funded take-home study of cannabis for the treatment of pain, and a co-investigator on cannabis studies addressing pain, as well spasticity in multiple sclerosis. Dr. Marcotte has served on the editorial boards of Neuropsychology and the Journal of the International Neuropsychological Society, was co-chair of the Research, Data and Technology subcommittee of the State of California Impaired Driving Task Force, and a member on the California Office on Traffic Safety Impaired Driving Blueprint Roundtable. He is co-editor of the book Neuropsychology of Everyday Functioning, 2nd Edition (Marcotte, Schmitter-Edgecombe & Grant)
Register to Attend

Monthly Journal Club - Dr. Ran Abuhasira, Cannabis is associated with Blood Pressure Reduction in Older Adults
2022-09-07 09:00 - 10:00 (America/Los_Angeles) | Society of Cannabis Clinicians
September 7, 2022
Speaker:
Ran Abuhasira, MD PhD,
Article:
Cannabis is Associated with Blood Pressure Reduction in Older Adults: A 24-hour ambulatory blood pressure monitoring study
Meet Dr. Ran Abuhasira
Department of Internal Medicine B, Rabin Medical Center, Beilinson Campus.
Dr. Abuhasira completed his PhD at the Cannabis Clinical Research Institute (CCRI) under the supervision of Prof. Victor Novack. The CCRI is part of the Clinical Research Center at Soroka University Medical Center in Beer-Sheva, Israel. His study focused on assessing the safety and efficacy of medical cannabis in the elderly population. His work was published in a number of papers and presented in scientific conferences worldwide.
Register to Attend

First International Congress on Medical Use of Cannabis and Entheogens
2022-09-02 08:00 - 2022-09-03 17:00 (America/Los_Angeles) | Lima, Peru
Tuesday, September 2, 2022 – Wednesday, September 3, 2022
Event Description
An academic conference with a clear objective, to bring together cannabis and entheogen experts to present scientific evidence and experience from their role in science and society; following the principles of ethics, empathy and with the human vision of medicine, for Peru and the world.

CSequence & The Society of Cannabis Clinicians Presents Journal Club: Cannabis vs. Opioids For Back Pain- Two New Studies
2022-07-01 09:00 - 10:30 (America/Los_Angeles) | Society of Cannabis Clinicians
The Society of Cannabis Clinicians Journal Club Featuring Dr. Dustin Sulak
Friday, July 1, 2022
Event Description

Join us for the upcoming SCC Journal Club featuring Dr. Dustin Sulak as he shares his presentation on “Cannabis vs. Opioids For Back Pain: Two New Studies!”
If you are not an SCC member, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC members, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member, click here.
Meet Dr. Dustin Sulak:
Dr. Dustin Sulak
Dustin Sulak, D.O. is an osteopathic physician, licensed in Maine as a general practitioner. He is an expert in integrative medicine, the intelligent combination of conventional and alternative approaches to healthcare. He has long been fascinated by mind-body medicine, spirituality in healthcare, and natural approaches to promoting health and healing. He is an expert in cranial and biodynamic osteopathy, a clinical hypnotherapist, Reiki sensei, practitioner of chi kung and yoga, and has studied with numerous conventional and alternative healers and physicians.
Dr. Sulak’s clinical practice focuses on treating refractory conditions in adults and children. He received undergraduate degrees in nutrition science and biology from Indiana University, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine, and completed an osteopathic internship at Maine-Dartmouth Family Medicine Residency. Dr. Sulak is the founder of Integr8 Health and Healer.com, a medical cannabis education resource. He is a passionate teacher of clinicians, patients and industry professionals, and sits on the board of directors of two nonprofits focused on cannabis education, The Society of Cannabis Clinicians and Patients Out of Time.

Register to Attend

The SCC Quarterly Meeting: Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics
2022-06-24 09:00 - 10:30 (America/Los_Angeles) | Society of Cannabis Clinicians
The Society of Cannabis Clinicians Quarterly Meeting Featuring Dr. Dustin Sulak
Friday, June 24, 2022
Event Description

Join us for the upcoming SCC Quarterly Meeting featuring Dr. Dustin Sulak as he shares his presentation on “Acidic Cannabinoids: Inactive Precursors or Powerful Therapeutics!”
If you are not an SCC member, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC member, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member, click here.
Meet Dr. Dustin Sulak:
Dr. Dustin Sulak
Dustin Sulak, D.O. is an osteopathic physician, licensed in Maine as a general practitioner. He is an expert in integrative medicine, the intelligent combination of conventional and alternative approaches to healthcare. He has long been fascinated by mind-body medicine, spirituality in healthcare, and natural approaches to promoting health and healing. He is an expert in cranial and biodynamic osteopathy, a clinical hypnotherapist, Reiki sensei, practitioner of chi kung and yoga, and has studied with numerous conventional and alternative healers and physicians.
Dr. Sulak’s clinical practice focuses on treating refractory conditions in adults and children. He received undergraduate degrees in nutrition science and biology from Indiana University, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine, and completed an osteopathic internship at Maine-Dartmouth Family Medicine Residency. Dr. Sulak is the founder of Integr8 Health and Healer.com, a medical cannabis education resource. He is a passionate teacher of clinicians, patients and industry professionals, and sits on the board of directors of two nonprofits focused on cannabis education, The Society of Cannabis Clinicians and Patients Out of Time.

Register to Attend

Australian Medicinal Cannabis Symposium
2022-05-20 08:45 - 2022-05-22 15:00 (Australia/Sydney)
The United in Compassion Australian Medicinal Cannabis Symposium began as a patient led movement that changed the law and inspired a new industry for the benefit of Australian patients. Their focus remains on patients and helping them with better access by providing better education of the health workforce and promoting development of a viable, professional and patient focused industry.
Patients, clinicians, researchers and industry come together to examine exciting developments and to hear from renowned experts from home and from around the globe.

MORE INFO >>

SCC & CSequence Presents Journal Club: "Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!"
2022-05-06 09:00 - 09:30 (America/Los_Angeles) | Society of Cannabis Clinicians
Friday, May 6, 2022 at 9am PDT / 12pm EDT
Research Presentation: SCC & CSequence Presents Journal Club: “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome!”
Speaker: Dr. Mihkail Kogan
Moderator: Zach Moore, PhD
Event registration link:
https://cannabisclinicians.tradewing.com/event/YsyEfdp5favrgo2r7
Join us for an educational discussion with Mikhail Kogan, MD as he highlights his recent research article “Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome.”
Learn More About Mikhail Kogan:

Dr. Mikhail Kogan, MD is a Medical Director, GW Center for Integrative Medicine, and the Assistant Professor, George Washington University School of Medicine and Health Sciences.
He is an Integrative Medicine Fellowship Director, Primary Care Internal Medicine, Integrative Geriatrics, Functional Medicine, Integrative Palliative Care Physician.
He is also the founder and Executive Director of ex-officio, of AIM Health Institute, a 501 (c) (3) non-profit organization
Dr. Kogan is a founding Board Member of the American Board of Integrative Medicine, and a Board Member of the Art of Healing Foundation.
Dr Kogan is a leader in the newly-established field of Integrative Geriatrics. He is the chief editor of the first definitive textbook of the field entitled “Integrative Geriatric Medicine ”, published by Oxford University Press as part of Andrew Weil Integrative Medicine Library series and is frequent speaker at a variety of international conferences on the topics of Integrative Medicine and Geriatrics, healthy aging, and geriatrics, as well as neurodegenerative diseases, and use of medical cannabis. Additionally, he has published in both Integrative and Geriatric topics in leading US-based journals.
Dr. Kogan currently serves as medical director of the GW Center for Integrative Medicine and associate director of the Geriatrics Fellowship Program. He is the founder and director othe George Washington University Integrative Geriatrics Fellowship Track and the director of the Integrative Medicine Track program at the George Washington University School of Medicine, as well as serving as part-time faculty member of the George Washington Institute for Spirituality and Health, and the GW Center for Aging, Health and Humanities.
In addition to his academic roles at George Washington University Dr. Kogan serves on a number of national boards and organizations including: the American Board of Integrative Medicine within the American Board of Physician Subspecialists (ABPS), ProCure Art, PlantMed, and others. Dr Kogan is also the founder and the chair of the board of AIM Health Institute, a 501(c)(3) non-profit organization in the Washington, D.C. metropolitan area that provides integrative medicine services to low-income and terminally ill patients regardless of their ability to pay.
For Dr. Mikhail Kogan, the practice of medicine, much like the rest of his life, has been a journey spanning many miles and many cultures, with valuable new learning and different perspectives accruing from each stage along the way. Those many experiences – here and abroad, in the classroom and the clinic, professionally and personally – have given Dr. Kogan the skills, , openness, and inquisitiveness that set him apart, and distinguish him as a committed and caring practitioner within integrative medicine.
Born in Moscow, in the former Soviet Union, Dr. Kogan emigrated with his family in his teens, first to Israel,and then to the United States, where he obtained his medical degree from the Drexel University College of Medicine in Philadelphia, Pennsylvania. He followed a Primary Care and Social Medicine Track residency in Internal Medicine at Montefiore Medical Center in New York City, and a fellowship in Geriatric Medicine at the George Washington University Medical Center in Washington, D.C., which led to a position as an assistant professor of medicine in the Division of Geriatrics and Palliative Care.
In addition to his training in conventional Western medicine, Dr. Kogan has actively pursued a number of other healing arts and practices that have shaped his understanding of and approach to patient care. He is a graduate of a two-year training course in craniosacral therapy–a subtle osteopathic modality that has a wide range of effectiveness for different conditions such as headaches, back pains, and fatigue. He has also completed a four-year program at the Suluk Academy, a teaching center based on the principles and traditions of Sufism, where he learned how to incorporate meditation, mindfulness, and different spiritual practices into his daily life and his work with the patients. Among his many other areas of study are courses in Nutrition, therapeutic use of vitamins, Functional Medicine, botanicals, and other alternative modalities.
Weaving those tools into the fabric of his medical practice has enabled Dr. Kogan to provide innovative and effective treatments to his patients with minimal use of invasive procedures or heavy reliance on medications and to understand the importance of self-exploration, awareness and positive lifestyle changes as essential milestones on his patients’ journeys towards better health. Dr. Kogan is dedicated to helping patients with Alzheimer’s disease identify and correct underlying metabolic drivers work, which is primarily based on Dr. Dale Bredesen’s research and newly created ReCode protocol.
Dr. Kogan practices Geriatric and Integrative Medicine in a variety of settings: at the George Washington Hospital, at the GW Center for Integrative medicine, as well as serving patients in home visits.
Register to Attend

SCC & CSequence Journal Club Presents: "State Medical Cannabis Programs: What Physicians Should Know And Consider" Hosted By Richard Cheng, JD, CHC
2022-04-15 11:00 - 12:30 (America/Los_Angeles) | Society of Cannabis Clinicians
Friday, April 15, 2022 at 11am PDT / 2pm EDT

Research Presentation: “State Medical Cannabis Programs: What Physicians Should Know And Consider”

Speaker: Richard Cheng, JD, CHC
Moderator: Zach Moore, PhD

Event registration link: https://cannabisclinicians.tradewing.com/event/Q5HfwtB9iCxhaMCed
Join us for a robust discussion with Richard Cheng, JD, CHC, as we learn more about “State Cannabis Laws.”

Learn More About Richard Cheng:
Richard Cheng, JD, CHC
Richard Cheng is a healthcare and cannabis regulatory and corporate attorney, specializing in representing healthcare providers and cannabis businesses. He is also a healthcare professional holding a degree in Occupational Therapy (BSOT).

Register to Attend

SCC Quarterly Meeting: Dr. Lauren Streicher, "The Use of Cannabinoids in Menopause"
2022-04-08 09:00 (America/Los_Angeles) | Society of Cannabis Clinicians
Event Description

Join us for the upcoming SCC Quarterly Meeting featuring Dr. Lauren Streicher as she shares her presentation on “The Use of Cannabinoids in Menopause.”
If you are not an SCC member, please click “Sign Up” at the top of the page in order to Register. The event is free for SCC member, and $20 for non-members. To learn more about the Society of Cannabis Clinicians or join as a member, click here.
Learn More About This Event:
There are over 60 million menopause women in the United States, and over 80% of those women experience debilitating and life shortening symptoms such as hot flashes and insomnia. Only 7% get a prescription to relieve those symptoms since there is a persistent (and false) perception that estrogen is dangerous. Many post menopause women are turning to cannabis. Dr. Lauren Streicher, a clinical professor of Obstetrics and Gynecology at the Feinberg School of Medicine, Northwestern University, and the Medical Director of the Northwestern Medicine Program for Menopause will discuss the potential role of cannabinoids in menopausal women.
Meet Dr. Lauren Streicher:

Lauren Streicher, MD is a clinical professor of obstetrics and gynecology at Northwestern University’s Feinberg School of Medicine, and the medical director of the Northwestern Medicine Center for Sexual Medicine and Menopause. She is a certified menopause practitioner of the North American Menopause Society, a member of the Sexual Medicine Society of North America, Inc., The International Society for the Study of Women’s Sexual Health, and The Scientific Network on Female Sexual Health and Cancer. In addition to authoring multiple scientific publications, she has written multiple consumer books. Her most recent releases are Slip Sliding Away: Turning Back the Clock on Your Vagina and Hot Flash Hell: A Gynecologist’s Guide to Turning Down the Heat.
Dr. Streicher is the medical correspondent for Chicago’s top-rated news program, the WGN Morning News, and has appeared multiple times on The Today Show, Good Morning America, The Oprah Winfrey Show, CNN, NPR, Dr. Radio, Nightline, Fox and Friends, The Steve Harvey Show, CBS This Morning, ABC News Now, NBC Nightly News, 20/20, and World News Tonight. She lives in Chicago with her writer-producer husband, Jason Brett, and their dog, KJ.

Register to Attend

CannX-Tel Aviv
2022-03-14 - 2022-03-15 | Tel Aviv, Israel
CannX Tel Aviv is the meeting point for global leaders in all areas of Medical Cannabis. First-hand knowledge and networks are essential in understanding the way forward within the complex ecosystem of medical cannabis. CannX 2022 will provide a unique opportunity to gather once again in-person in the beautiful city of Tel Aviv. Join the world’s most influential scientists, clinicians, entrepreneurs, investors, policymakers, and thought leaders for the ultimate opportunity to make an impact in the field. We haven’t had the chance to meet since 2020 due to the restrictions imposed by the Covid-19 pandemic and look forward to seeing you in person in Israel’s most cosmopolitan and vibrant city – Tel Aviv.

Monthly Journal Club: Bonni Goldstein, MD & Itzhak Kurek, PhD - Cannabis-Responsive Biomarkers & Autism Spectrum Disorder
2022-03-04 09:00 (America/Los_Angeles)
March 4, 2022 at 9am PST / 12pm EST

Article: Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.

Speakers: Bonni Goldstein, MD & Itzhak Kurek, PhD
Moderator: Zach Moore, PhD

Event registration link: https://cannabisclinicians.tradewing.com/event/Q5HfwtB9iCxhaMCed
Join us for a robust discussion with Bonni Goldstein, MD & Itzhak Kurek, PhD moderated by Zach Moore, PhD as we discover their newest publication, “Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.”
Autism spectrum disorder (ASD) is a group of neurodevelopmental conditions that impact behavior, communication, social interaction, and learning abilities. Treatment of ASD with medical cannabis (MC) shows promising results in reducing the severity of certain behavioral aspects. The goals of this observational study are to demonstrate the potential of metabolic biomarkers to (1) objectively determine the impact on metabolites of MC treatment and (2) suggest the metabolic pathways of children with ASD, who respond to MC treatment.

Learn More About Dr. Bonni Goldstein:
Dr. Bonni Goldstein
Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness & Education, a California-based medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions. She completed her internship and residency at Children’s Hospital Los Angeles, where she also served as chief resident. After years of working in the specialty of Pediatric Emergency medicine, she developed an interest in the science of medical cannabis after witnessing its beneficial effects in an ill friend. Over the last 13 years she has evaluated thousands of patients for use of medical cannabis and is recognized as an expert in the clinical application of cannabis therapeutics. She has a special interest in treating children with intractable epilepsy, autism, cancer and other conditions. Her latest book, “Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain” was published in September 2020 by Little, Brown Spark. Dr. Goldstein recently co-authored a peer-reviewed article researching the use of Cannabis-Responsive biomarkers to document cannabis treatment efficacy, guide clinical decision-making and improve outcomes.

Learn More About Itzhak Kurek, PhD:
Itzhak Kurek, PhD
Itzhak Kurek, PhD is the co-founder and CEO of Cannformatics, Inc. a San Francisco-based biotechnology startup developing saliva-based Cannabis-Responsive™ biomarkers as a universal tool for the objective measurement of the physiological impact of any cannabinoid-based treatment. He has executive and research management experience in the Ag-Biotech, Nutritional Supplements and Biobased Products businesses. Previously he held positions at Solix Algredients, Kiverdi, Pioneer Hi-Bred (DuPont) and Maxygen. He has published over 70 peer-reviewed scientific papers and patents. Dr. Kurek received his Ph.D. in Plant Sciences from Tel Aviv University and completed his postdoctoral research at the University of California, Davis. Dr. Kurek has also conducted research at the Technical University of Munich, John Innes Center Norwich, C.N.R.S Bordeaux and the Lawrence Berkeley National Laboratories.

REGISTER TO ATTEND

Cannabis Science & Industry Congress
2022-01-27 - 2022-01-29 | Parque Viva Main Gate, Alajuela, Costa Rica
January 27-29, 2022 | San Jose, Costa Rica
The Cannabis Congress has partnered with the Society of Cannabis Clinicians to develop the Medical Track of the event featuring clinicians and researchers presenting the latest research and clinical findings on the therapeutic applications of cannabis. Doctors from Latin America, the United States, the EU, and Canada will be addressing an array of the most sought-after clinical topics from pain, sleep, epilepsy, mental health and more, to clinician activism, historical perspectives and indigenous knowledge of cannabis medicine.

MORE INFO >>
